AIS and START Grade With Films Transferring in Disaster Management (START)

June 14, 2023 updated by: Chia-hsi Chen

Abbreviated Injury Scale (AIS) Grading and Simple Triage and Rapid Treatment (START) Triage Method Combined With Film Transferring on Instant Message Improve Difference of Disaster Triage and Disaster Management

Disaster medical teams are formed by hospitals in response to the manpower needs of a large number of injured and sick patients. The current planning of hospitals for a large number of disaster medical manpower is too superficial. The application of today's inspection methods in the treatment of a large number of injured patients is not as good as it is. Therefore, understanding the scene situation has become the key point of manpower deployment. Today's internet transmission speed and computer artificial intelligence technology are very different from 9 years ago. The investigators adopt one more simple and easy-to-operate inspection method and use artificial intelligence technology to assist.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Disaster medical teams are formed by hospitals in response to the manpower needs of a large number of injured and sick patients. However, the current planning of hospitals for a large number of disaster medical manpower is too superficial. The application of today's inspection methods in the treatment of a large number of injured patients is not as good as it is. Therefore, understanding the scene situation has become the key point of manpower deployment. Today's network transmission speed and computer artificial intelligence technology are very different from 9 years ago. The image transmission of the communication software to understand the scene will help the hospital's manpower deployment or should the investigators adopt a more easy-to-operate inspection method and use artificial intelligence technology to assist Implementation method: 82 patients with a large number of injuries in the Ali mountain traffic accident over the years were included, medical records were reviewed. The photos of patients recorded at the hospital site and existing vital signs of the patients were mainly used to make grading of the traditional STAR triage and the AIS to understand the possible differences in image interpretation and injury detection. Excluding patients with incomplete clinical data of treatment, the statistical methods of the samples were Correlation analysis and Wilcoxon signed rank test, and the p value of statistical significance was 0.05

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Taiwan
      • Chiayi City, Taiwan, 60069
        • St. Martin De Porres Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All patients in the high mountain disaster

Description

Inclusion Criteria:

  • All patients in the high mountain disaster

Exclusion Criteria:

  • Excluding patients with incomplete clinical data of treatment and clinical films

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Abbreviated Injury Scale (AIS) Grading and Simple Triage and Rapid Treatment (START) Triage Method Combined with Film Transferring on Instant Message Improve Difference of Disaster Triage and Disaster Management
Time Frame: 3 months
The AIS and START grading are usually defined in trauma disaster when patients are sent off to emergency room. The AIS is an anatomically-based injury severity scoring system that classifies each injury by body region on a 6 points scale from minor to maximal (currently untreatable) status. The START grading assign the disaster patients to one of the following four categories: grade 0: deceased/expectant (black), grade1: immediate (red), grade 2: delayed (yellow), grade 3: minor (green) The investigators use the recorded exterior photo, radiological film and vital sign data of the injured patients to re-define the AIS and START grading. The results are compared with the original data that are documented in our medical records and want to know that the consistency exist between two groups. Excluding patients with incomplete clinical data of treatment. Statistical methods were Correlation analysis and Wilcoxon signed rank test. The p value of statistical significance was 0.05
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Chia-hsi Chen

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Chia-Hsi Chen, Dr, St. Martin De Porres Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 10, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 14, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 27, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 3, 2022

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 16, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 14, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • StMartinDPH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We have prepared all raw data for further IRB evaluation regularly.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings